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Abstract
A kinase interacting protein 1 (AKIP1) is a molecular regulator of protein kinase A and nuclear factor kappa B
signalling. Recent evidence suggests AKIP1 is increased in response to cardiac stress, modulates acute ischemic
stress response, and is localized to mitochondria in cardiomyocytes. The mitochondrial function of AKIP1 is,
however, still elusive. Here, we investigated the mitochondrial function of AKIP1 in a neonatal cardiomyocyte model
of phenylephrine (PE)-induced hypertrophy. Using a seahorse flux analyzer we show that PE stimulated the
mitochondrial oxygen consumption rate (OCR) in cardiomyocytes. This was partially dependent on PE mediated
AKIP1 induction, since silencing of AKIP1 attenuated the increase in OCR. Interestingly, AKIP1 overexpression alone
was sufficient to stimulate mitochondrial OCR and in particular ATP-linked OCR. This was also true when pyruvate
was used as a substrate, indicating that it was independent of glycolytic flux. The increase in OCR was independent
of mitochondrial biogenesis, changes in ETC density or altered mitochondrial membrane potential. In fact, the
respiratory flux was elevated per amount of ETC, possibly through enhanced ETC coupling. Furthermore,
overexpression of AKIP1 reduced and silencing of AKIP1 increased mitochondrial superoxide production, suggesting
that AKIP1 modulates the efficiency of electron flux through the ETC. Together, this suggests that AKIP1
overexpression improves mitochondrial function to enhance respiration without excess superoxide generation,
thereby implicating a role for AKIP1 in mitochondrial stress adaptation. Upregulation of AKIP1 during different forms
of cardiac stress may therefore be an adaptive mechanism to protect the heart.
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Introduction
A kinase interacting protein 1 (AKIP1) is a small 23 kDa
protein originally identified as a breast cancer associated gene
(BCA3) [1]. In humans, there are three splice variants, the full-
length protein (AKIP1a), one that lacks the third exon (AKIP1b),
and one that lacks the third and fifth exon (AKIP1c). In contrast,
only the full-length protein is present in rodents [2]. It has no
homologies to other proteins, is devoid of particular catalytic
domains and is therefore believed to have a role as an adaptor
or structural intracellular protein. AKIP1 localizes to the
cytoplasm, nucleus, and mitochondria and associations with
proteins with different sub-cellular localizations have been
reported, including PKA [3], NFκB [4], apoptin [5], RAC1 [6],
TAP73 [7] and AIF [8]. These varied sites of cellular localization
suggest that AKIP1 may have multiple functions in the cell. In
cancer cell lines a role for AKIP1 in nuclear-cytoplasmic
shuttling of PKA and NFκB has been proposed [3,4,9,10], but
AKIP1 may also be involved in apoptosis [5,7]. AKIP1 has been
shown to localize to mitochondria in both cancer cells and
cardiomyocytes, but its functional role in mitochondria is still
elusive [7,8].
AKIP1 has been mainly studied in cancer cell lines, but is
also expressed in many normal, non-tumor, cells in different
organs. AKIP1 is abundantly expressed in cardiac tissue
predominantly in cardiomyocytes [11]. In a gene array study we
PLOS ONE | www.plosone.org 1 November 2013 | Volume 8 | Issue 11 | e80815
identified AKIP1 as a differentially expressed gene that was
significantly upregulated in animal models of pathological
cardiac hypertrophy and heart failure, including pressure
overload and post-myocardial infarction (MI) remodelling [11];
however, exercise mediated “physiological hypertrophy” also
increased AKIP1 expression [12]. Cardiac hypertrophy is
initially adaptive in cardiomyocytes to compensate for
sustained wall stress, but becomes maladaptive during
sustained pathological stress. Interestingly, mitochondrial
function is improved during physiological hypertrophy, but
diminishes upon sustained pathological hypertrophy [13]. It is
possible that AKIP1 may be regulating the compensation
phase of pathologic hypertrophy and exercise-induced
physiologic hypertrophy through regulation of mitochondrial
function. Mitochondria isolated from AKIP1 gene transferred
hearts showed amongst others, enhanced calcium tolerance,
and decreased mitochondrial cytochrome C release upon
ischemic stress. Interestingly, AKIP1 overexpression could
protect cardiac function in an ex vivo mouse ischemia/
reperfusion model [8]. Here we test the direct effects of loss or
overexpression of AKIP1 on mitochondrial function.
Materials and Methods
Ethics statement
Animal use for these studies was in accordance with the NIH
Guide for the Care and Use of Laboratory Animals. The study
was submitted to, and approved by, the Committee for Animal
Experiments of the University of Groningen (Permit Number:
DEC6002). All efforts were made to minimize suffering.
Isolation and culturing of primary cardiomyocytes
Neonatal rats of 1-3 day old were euthanized by
decapitation, hearts excised and atria were removed. Primary
neonatal rat ventricular cardiomyocytes (NRVCs) were isolated
as previously described [14,15]. Cardiomyocytes were grown in
DMEM (Sigma D5671, Missouri, USA) supplemented with 5%
fetal calf serum (FCS: Sigma F9665, Missouri, USA) and
penicillin-streptomycin (100U/ml-100μg/ml; Sigma P0781,
Missouri, USA). Adenoviral constructs were generated with the
ViraPowerTM adenoviral expression system from Invitrogen as
described previously [16]. Primers used for cloning are listed in
Table S1. For adenoviral infections, cardiomyocytes were
infected with an MOI of 25 one day after isolation, in medium
with 5% FCS, and starved the next day for 48 hours. Similar
culture conditions were employed for the non-infected cells or
control virus infected cells that served as controls. For cells
stimulated with phenylephrine (PE), 24 hours after starvation
PE (50 μM) was added for 24 hours after which assays were
performed.
Seahorse mitochondrial flux analyses
To measure the rate of oxidative phosphorylation in intact
cardiomyocytes, a Seahorse metabolic flux analyzer was used
(Seahorse Biosciences, Massachusetts, USA). NRVCs were
seeded at a density of 100,000 cells/well in 24 well Seahorse
assay plates. Cells were treated as described above. One hour
before initiation of measurements, medium was replaced with
XF medium supplemented with 10 mM glucose or 1 mM
pyruvate and incubated for 1 hour in a 37°C incubator (without
CO2). Three baseline oxidative consumption rate (OCR)
measurements were performed, followed by injection with
oligomycin (1 μM) to measure the ATP linked OCR. The
uncoupler FCCP (0.5 μM) was used to determine maximal
respiration and rotenone (1 μM) and antimycin A (1 μM) were
injected to determine the non-mitochondrial respiration.
Experimental treatments were performed on 3-4 wells of each
plate as technical replicates and each experiment had at least
3 biological replicates. OCR was normalized for the amount of
cellular protein in each well.
Real time PCR
Total RNA was isolated using a kit (Bioke, the Netherlands)
and cDNA was synthesized using a reverse transcription kit
(Qiagen, the Netherlands) following manufactures instructions.
Total DNA was isolated using a kit (Qiagen, the Netherlands)
following manufactures instructions. Relative gene expression
was determined by quantitative real time PCR (RT-PCR) on a
Bio-Rad CFX384 real time system using SYBR Green dye
(Bio-Rad, California, USA). Gene expressions were corrected
for reference gene values (cyclophilin A or GAPDH), and the
calculated values were expressed relative to the control group
per experiment. Primer sequences are listed in Table S2.
Western blot
Protein was isolated in RIPA buffer (50 mM Tris pH 8.0, 1%
nonidet P40, 0.5% deoxycholate, 0.1% SDS, 150 mM NaCl)
supplemented with 10 μl/ml phosphatase inhibitor cocktail 3
(Sigma p2850, Missouri, USA), protease inhibitor cocktail
(Roche, 11873580001, Switzerland) and 1mM
phenylmethylsulfonyl fluoride (PMSF) (Roche,10837091001,
Switzerland). Protein concentration was determined with a DC
protein assay kit (Bio-Rad, California, USA). Equal amounts of
proteins were separated by SDS-PAGE and proteins were
transferred to PVDF or nitrocellulose membranes. For
detection of specific proteins, the following antibodies were
used: a custom-made rabbit polyclonal anti-AKIP1 antibody,
anti-total OXPHOS antibodies cocktail (Abcam, Cambridge,
United Kingdom), and monoclonal anti-GAPDH antibody
(Fitzgerald, Massachusetts, USA) served as a loading control.
After incubation with secondary antibodies, signals were
visualized with ECL and analyzed by densitometry (Syngene,
Cambridge, United Kingdom).
Citrate synthase assay
Whole cell citrate synthase activity was measured using an
enzyme assay kit (Sigma, Missouri, USA) according to the
manufactures instructions. Cell lysates were prepared using
the CelLytic M Cell Lysis Reagent and protein concentrations
were measured with a DC protein assay kit (Bio-Rad,
California, USA). 8 μg of protein was mixed with Acetyl
CoenzymeA (Acetyl CoA), 5,5’-Dithiobis-(2-nitrobenzoic acid)
(DTNB), and assay buffer in a 96 well plate. The reaction was
initiated by adding Oxaloacetate (OAA) into the mixture and
total activity was measured. Absorbance was measured at 412
AKIP1 Enhances Mitochondrial Respiration
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nm using a multiwall spectrophotometer following a kinetic
program. Triplicate measurements were performed on each
sample and 5 independent samples were measured for each
group.
Determination of mitochondrial membrane potential
and ROS production
Mitochondrial membrane potential (ΔΨm) was assessed by
tetramethylrhodamine ethyl ester (TMRE; Life Technologies
Europe BV, The Netherlands) following the manufacturers
instructions. In brief, cells were seeded at a density of 40,000
cells/well in black 96 well plates and cultured as described
above. TMRE was added at a final concentration of 100 nM
with 20 min incubation at 37 °С. Cells were subsequently
washed with 0.2% BSA in PBS, and fluorescence was
measured at 575 nm with a SynergyH4 Hybrid Reader (BioTek,
Vermont, USA). As a control, FCCP (1 μM) was added to some
wells. ROS production was determined in a similar way using
MitoSOX red mitochondrial superoxide indicator (Life
Technologies, California, USA). Cells were plated in 96 well
plates and treated as above. On the day of measurement, the
cells were incubated with MitoSOX (5 μM) in KRPH buffer
(20mM HEPES, 5 mM KH2PO4, 1 mM MgSO4, 1 mM CaCL2,
136 mM NaCl, 4.7 mM KCl, pH 7.4) for 10 min at 37 °С, and
thereafter washed three times with the same buffer.
Fluorescence was measured using excitation/emission maxima
of 510/580 nm with a SynergyH4 Hybrid Reader (BioTek,
Vermont, USA). For both assays, each experiment had four
technical and three biological replicates.
Statistical analysis
All values are presented as mean ± standard error of the
mean (SEM). Independent-samples t-test was performed to
compare the difference between both groups. One-way
ANOVA with post-hoc test was used to compare the difference
between 4 groups with homogeneity of variances. Kruskal-
Wallis test was used to compare the difference between 4
groups with nonparametric variances. P<0.05 was considered
to be significant. SPSS software (PASW Statistics 18) was
used in the statistics analysis.
Results
AKIP1 silencing attenuates PE induced OCR
We have recently shown that AKIP1 gene expression can be
induced by PE, a pharmacologic inducer of hypertrophy [11].
We confirm this finding in the current data and, moreover, show
that AKIP1 protein expression is induced by PE in NRVCs
(Figure 1A). PE has been shown to increase respiration in
NRVCs [17]. We wondered whether AKIP1 plays a role in
modulating PE-induced mitochondrial respiration. Addition of
PE to NRVCs resulted in a marked increase in OCR (doubling
in OCR, see Figure 1B). Addition of oligomycin (oligo), an ATP-
synthase inhibitor, reduced OCR both in control and PE treated
cells. This difference in OCR between basal and oligomycin
treated conditions, is the ATP-linked OCR, which was higher in
the PE treated cells (Figure 1C). Subsequent addition of FCCP,
an uncoupling agent, provided the maximal, uncoupled, OCR.
Finally, antimycin-A and rotenone (AR) were added to the cells
to block mitochondrial respiration (complex III and complex I
inhibitors, respectively). The basal OCR was subsequently
corrected for this non-mitochondrial OCR to obtain the
mitochondrial specific respiration, which was significantly
elevated in PE treated cells (Figure 1C). To investigate whether
this increase in mitochondrial respiration required AKIP1, we
used an adenoviral small interfering RNA system to silence
AKIP1. Silencing of AKIP1 resulted in a 90% reduction of
AKIP1 protein levels (Figure 1D). Interestingly, AKIP1 silencing
reduced, albeit not significantly, mitochondrial OCR in NRVCs
(Figure 1E, F). Upon PE addition, this reduction was much
more pronounced and mitochondrial OCR was significantly
attenuated (Figure 1E, F). AKIP1 silencing could also inhibit PE
induced ATP-linked OCR, albeit just not significant (Figure S1).
Thus, AKIP1 silencing attenuated PE induced mitochondrial
OCR, indicating a role for AKIP1 in mitochondrial respiration.
AKIP1 induces mitochondrial OCR
To investigate whether AKIP1 itself could induce
mitochondrial OCR, we overexpressed AKIP1 in NRVCs
(Figure 2A). AKIP1 increased basal OCR by almost 80 %
(Figure 2B). Blocking the mitochondrial respiratory chain with
AR almost fully blocked this OCR, suggesting that this was
specific for mitochondrial respiration. The calculated
mitochondrial specific OCR was 4.8 pmoles O2/min/μg protein
in control and 8.5 pmoles O2/min/μg protein in AKIP1
overexpressing cells (Figure 2C). The oligomycin effects on
OCR suggested the increase was linked to ATP synthesis
(Figure 2D). Also, the maximal respiratory rate was increased,
as determined by FCCP uncoupling; however, this was not
significant. The reserve capacity, the difference between
maximal and basal respiration, remained similar (Figure 2B).
To further investigate the role of AKIP1 in mitochondrial
oxidation and to test whether this was independent of the
glycolytic flux we performed a similar experiment with pyruvate
as a substrate. Pyruvate can be converted into acetyl-CoA in
mitochondria and directly be used as a substrate in the TCA
cycle. Interestingly, with pyruvate similar results were obtained
as with glucose (Figure 2E-G), indicating that these changes in
mitochondrial respiration were independent of glycolytic flux.
This was further confirmed by the absence of changes in
extracellular acidification rate in these cells.
AKIP1 does not induce mitochondrial biogenesis
AKIP has been shown to modulate SIRT1 function, and the
latter has been shown to control the expression of PGC1α, a
master transcriptional regulator for mitochondrial biogenesis.
Therefore, AKIP1 induced OCR could potentially be a result of
an increase in mitochondrial biogenesis. In AKIP1
overexpressing cells PGC1α was not significantly increased
(Figure 3A). Also expression of ERRα and NRF1, downstream
targets of PGC1α involved in the regulation for mitochondrial
biogenesis were not altered (Figure 3B, C). To corroborate this
finding, we also determined the ratio between mitochondrial
DNA (mtDNA) versus nuclear DNA (nDNA), a generally
accepted measurement of mitochondrial density. PCR analysis
AKIP1 Enhances Mitochondrial Respiration
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was performed on the nuclear gene TRPM-2 and the
mitochondrial gene CYTB. The ratio between mtDNA and
nDNA was similar in control and AKIP1 overexpressing cells
indicating that mitochondrial biogenesis was not increased
(Figure 3D). To further confirm this by an independent method
we assessed citrate synthase activity which was not affected
by AKIP1 overexpression (Figure 3E). Multiple data support the
notion that AKIP1 does not stimulate mitochondrial biogenesis.
No increase in OXPHOS levels in AKIP1 overexpressing
cells
The altered respiratory rates could also result from changes
in expression of electron transport chain (ETC) complexes.
Western blotting with an OXPHOS antibody cocktail,
recognizing multiple subunits of the ETC, did not show an
increase in the protein levels of ETC-complexes (Figure 4A, B).
On the contrary, a significant decrease could be observed in
subunits of complex I, II, III and IV in AKIP1 overexpressing
cells. Also complex V appeared to be somewhat reduced,
albeit not significant. This suggests that AKIP1 overexpression
enhances the efficiency of mitochondrial ETC. We also
analyzed changes in mitochondrial membrane potential using
the fluorophore TMRE. As shown in Figure 4C, no significant
difference between control and AKIP1 infected cells was
observed in TMRE fluorescence. Treatment with FCCP, a
depolarizing agent did strongly reduce TMRE signal, confirming
membrane potential specificity (Figure 4C). Thus despite lower
OXPHOS levels, AKIP1 overexpressing did not significantly
affect the mitochondrial membrane potential, suggesting a
more efficient mitochondrial respiration.
Figure 1.  AKIP1 silencing attenuates PE-induced OCR.  A. A representative Western blot is shown with control and PE treated
NRVCs samples. Blots were probed with anti-AKIP1 antibody and anti-GAPDH as a loading control. B. PE induced OCR in NRVCs.
Metabolic flux in cardiomyocytes was determined with a Seahorse flux analyzer in the presence of 10 mM glucose. Addition of the
ATP synthase inhibitor oligomycin (oligo), the uncoupler FCCP and the respiratory chain inhibitors antimycin A and rotenone (AR)
are indicated. C. Mitochondrial OCR (difference between basal and AR treated levels) and ATP-linked OCR (difference between
basal and oligomyin treated levels) are shown. OCR was corrected for total protein levels in each well (pmoles O2/min/μg) (*P<0.05
as compared to cont, n=4). D. A representative Western blot is shown of cells treated for 72 hours with control and siAKIP1
adenovirus. Blots were probed with anti-AKIP1 antibody and anti-GAPDH as a loading control. E. Silencing of AKIP1 can limit PE
induced OCR. OCR was measured as above. F. Quantification of mitochondrial OCR showed significant lower OCR in siAKIP1+PE
group compared to Cont+PE group (*P<0.05 as compared to cont group, #P<0.05 compared to siAKIP1 group, &P<0.05 compared
to cont+PE group, n=4). All values are presented as mean ± SEM.
doi: 10.1371/journal.pone.0080815.g001
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AKIP1 reduces superoxide formation
Since OCR was elevated in AKIP1 overexpressing cells, we
analyzed whether the potential of mitochondrial to generate
reactive oxygen species would be altered. We assessed
superoxide generation using MitoSOX, a fluorophore which is
activated by superoxide oxidation. Interestingly, MitoSOX
signal in AKIP1 overexpressing cells was about half as
compared to control cells (Figure 5A). To exclude that this
could be due to increased levels of oxygen radical scavenging
systems, we also analysed the expression of manganese-
superoxide dismutase (SOD2) and glutathione peroxidise
(GPX4). Neither of these genes were upregulated (Figure 5B,
C), indicating that AKIP1 does not induce the anti-oxidant
response. In contrast, AKIP1 silencing resulted in increased
ROS production (Figure 5D). Together, this suggests that
AKIP1 overexpression improves mitochondrial function to
enhance respiration without excess generation of ROS
implicating a role for AKIP1 in mitochondrial stress adaptation.
Discussion
AKIP1 protein is expressed in many organs, and in cardiac
tissue a role in mitochondrial function has been suggested [8].
Although its role at mitochondria is still elusive, AKIP1 localizes
to and fractionates with mitochondria [7,8]. Here we
investigated the effect of AKIP1 in mitochondrial respiration in
neonatal rat cardiomyocytes. Treatment of cells with PE
induced AKIP1 expression and increased OCR. Interestingly,
AKIP1 overexpression on its own was sufficient to induce
mitochondrial OCR, whereas AKIP1 silencing could attenuate
PE induced OCR. We further determined that these effects
were independent of mitochondrial biogenesis and changes in
ETC component density. The increase in respiratory function
was not associated with increased ROS formation, suggesting
that AKIP1 overexpression may be a means to enhance the
efficiency of mitochondrial function in setting of cardiac stress.
Having effects independent of structural changes to
mitochondria that could take time to manifest (i.e., biogenesis
Figure 2.  AKIP1 overexpression induces mitochondrial OCR.  A. Using an adenoviral construct, rat AKIP1 was overexpressed
in NRVCs. Western blots of control and AKIP1 overexpressing cells were probed with anti-AKIP1 antibody and anti-GAPDH as a
loading control. Quantification of 3 blots is shown in the bar diagram (*P<0.05 as compared to cont group). B. AKIP1 induced OCR
in NRVCs. Metabolic flux in cardiomyocytes was determined in the presence of 10 mM glucose. Addition of different inhibitors is
indicated. C. Mitochondrial OCR of control and AKIP1 overexpressing cells is shown. D. ATP-linked OCR of control and AKIP1
overexpressing cells is shown. In all cases OCR was corrected for total protein levels in each well (pmoles O2/min/μg) (*P<0.05 as
compared to cont group, n=8). E-G. AKIP1 induced OCR in NRVCs in the presence of 1 mM pyruvate. The experiment was
performed as above, but using pyruvate as substrate instead of glucose (*P<0.05 as compared to cont group, n=4). All values are
presented as mean ± SEM.
doi: 10.1371/journal.pone.0080815.g002
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and protein synthesis to increase ETC components) suggest
that localization and stress induced expression and/or
translocation of AKIP1 may be important regulatory functions of
AKIP1 in the cell.
In concordance with a previous study [17], we showed that
PE induced mitochondrial respiration in cardiomyocytes. PE
also induced AKIP1 expression and silencing of AKIP1 could
attenuate PE induced alteration in mitochondrial function.
Interestingly, AKIP1 overexpression was itself sufficient to
increase OCR. Since oxygen consumption was also increased
with pyruvate as a substrate, this was independent of potential
glycolytic effects. Together these data indicate that AKIP1 has
a contributory role in PE induced mitochondrial respiration.
Since AKIP1 localizes to the nucleus and has been shown to
modulate transcription via NFκB and SIRT1 in cancer cell lines
[10,18], the mitochondrial changes may be a result of altered
transcription of nuclear encoded mitochondrial genes. We
investigated expression of numerous genes encoding
mitochondrial proteins, but did not observe any obvious
differences. SIRT1 modulation has also been shown to affect
PGC1α transcription, a well-known activator of mitochondrial
biosynthesis [19]. PGC1α and other downstream mitochondrial
biosynthesis genes, like ERRα and NRF1, were not
significantly altered. Moreover, mitochondrial numbers were not
increased in these cells. Thus, although we cannot rigorously
exclude the possibility that AKIP1 modulates mitochondrial
function via transcriptional regulation, we currently find this
explanation unlikely.
Figure 3.  AKIP1 does not induce mitochondrial biogenesis.  A-C. Expression of mitochondrial biogenesis controlling genes
PGC1α , ERRα and NRF1 was determined by RT-PCR in control and AKIP1 overexpressing NRVCs. Relative expression levels
were normalized by expression levels of the household gene, cyclophilin A. No significant difference was observed between groups
(n=3-6). D. Nuclear DNA (TRPM-2) to mitochondrial DNA (CYTB) ratio was determined by RT-PCR on DNA isolated from control
and AKIP1 overexpressing cells. No statistical significant difference was observed between groups (n=3). E. Citrate synthase
activity was measured on whole cell lysates from control and AKIP1 overexpressing cardiomyocytes as described in method
section. No statistical significant difference was observed between groups (n=5). All values are presented as mean ± SEM.
doi: 10.1371/journal.pone.0080815.g003
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In AKIP1 overexpressing cells lower levels of OXPHOS
components were observed. Nevertheless, mitochondrial
membrane potential was similar as compared to control cells
and oxygen consumption rate was higher. The flux per ETC
complex must therefore be considerably higher in AKIP1
overexpressing cells accounting for the higher efficiency. ROS
production on the other hand was attenuated suggesting that
the enhanced respiration was coupled and resulted in energy
production rather than mitochondrial dysfunction. Diminished
ROS production has recently been observed in mitochondria
from AKIP expressing adult cardiomyocytes, further stressing
that this is a mitochondrial specific effect [8]. Within
mitochondria at least ten different enzymes contribute to ROS
formation, but ETC complexes I and III are believed to be the
major sites of superoxide production [20-22]. Moreover, as we
observed changes in the levels of components of these
complexes, it is likely that AKIP1 exerts its effects by
modulating ETC in some way. It is possible that AKIP1
interacts with mitochondrial localized proteins, possibly
components of the ETC, to enhance function and decrease
ROS generation. Nevertheless, other factors like mitochondrial
ultrastructural or morphological changes in AKIP1
overexpressing cells, might also contribute to changes in
mitochondrial function. Cardiac hypertrophy and failure are also
associated with changes in multiple components of the ETC.
However, even within the same model and study, divergent
responses in different ETC components have been observed,
underscoring the complex regulatory networks that controls
cardiac energy production [23-25]. How AKIP1 modulates the
levels and function of these complexes will therefore require
further investigations.
Conditions that trigger hypertrophy and heart failure
formation, as well as ischemia/reperfusion, trigger AKIP1
expression in the heart [8,11]. Increased AKIP1 levels result in
more efficient mitochondrial respiration and reduced ROS
formation. However, despite the presence of higher AKIP1
levels under these conditions, decreased mitochondrial
function and increased ROS formation has been reported with
multiple forms of cardiac stress [26-28]. Also, in PE treated
cardiomyocytes ROS production is increased [29], despite
increased AKIP1 expression. This apparent contradiction might
be explained by the fact that all these conditions result in
profound metabolic and mitochondrial changes. The increase
in AKIP1 expression under these conditions might therefore be
an adaptive response to limit ROS production (Figure 6). This
is comparable with genes like SOD and catalase, which
encodes enzymes that scavenge ROS and are expressed only
when ROS levels are high [30]. It will therefore also be
interesting, whether absence of AKIP1 makes cells more
vulnerable to cardiac stress conditions. Alternatively, since
increased AKIP1 expression has also been reported during
physiological hypertrophy (exercise), AKIP1 expression may be
induced to enhance mitochondrial performance during cardiac
stress events. Many factors that are shown to be compensatory
in heart failure (e.g., natriuretic peptides, caveolins, etc) show
initial patterns of upregulation that ultimately lead to heart
failure, however, these same factors have a potential protective
role in heart failure when they are overexpressed [31-33]. Such
may be the case for AKIP1 expression. During sustained
stress, other metabolic and mitochondrial alterations might
subsequently result in deterioration of mitochondrial function
and increased ROS production. Obviously this still begs the
question, why AKIP1 expression is not continuously high, since
improved mitochondrial respiration would be beneficial under
all conditions. There could be multiple reasons; first depending
on its localization AKIP1 has also different functions besides
regulating mitochondrial respiration. Moreover, ROS is a
double-edged sword. High levels are detrimental causing DNA
and protein damage, whereas low levels are beneficial and are
required for cell signalling [28,34]. Therefore sustained high
expression of AKIP1 under normal conditions might interfere
with other cellular processes.
All together, we have shed light on the role of AKIP1 in
cardiomyocyte energy generation. In particular, we have shown
Figure 4.  OXPHOS levels are reduced in AKIP1 overexpressing cells.  A. Western blot analysis was performed on proteins
isolated from control and AKIP1 overexpressing NRVCs, anti-total OXPHOS antibody cocktail was used to determine ETC protein
levels. GAPDH was used as loading control. Representative blot is shown. B. Quantification of 4 independent experiments is shown
in the bar diagram (*P<0.05 as compared to cont, n=4). C. Mitochondrial potential was measured using TMRE in control and AKIP1
overexpressing cells. As a control the ionophore FCCP was added to reduce membrane potential (*P<0.05 as compared to cont,
#P<0.05 as compared to AKIP1 group, n=4). All values are presented as mean ± SEM.
doi: 10.1371/journal.pone.0080815.g004
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that AKIP1 can improve mitochondrial function in
cardiomyocytes resulting in increased respiration without
enhanced ROS production. Activating AKIP1 could therefore
have cell protective effects, whereas interfering with its function
may be detrimental.
Figure 5.  AKIP1 reduces superoxide formation.  A. Mitochondrial ROS was determined using MitoSOX fluorophore in control
and AKIP1 overexpressing cells. Significant less ROS signal was observed in AKIP1 group (*P<0.05 compared to cont, n=6). B and
C. Anti-oxidant genes SOD2 and PGX4 were determined by RT-PCR, relative gene expression was normalized by expression
levels of the household gene, cyclophillin A. No significant differences were observed between groups (n=6). D. Mitochondrial ROS
was determined as above in control and AKIP1 silenced cells. Significantly increased ROS signal was observed in the AKIP1
silenced cells (*P<0.05 compared to cont, n=4). All values are presented as mean ± SEM.
doi: 10.1371/journal.pone.0080815.g005
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Figure 6.  Schematic model of the role of AKIP1 in
modulating OCR and ROS formation.  PE induced OCR and
induced ROS formation in mitochondria. PE also induced
AKIP1 expression and AKIP1 was able to attenuate ROS
formation, but stimulate OCR. AKIP1 silencing experiments
confirmed this role of AKIP1 in controlling OCR and ROS
production. Together this indicates that AKIP1 improves
mitochondrial function.
doi: 10.1371/journal.pone.0080815.g006
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Supporting Information
Figure S1.  AKIP1 silencing and ATP-linked OCR. OCR was
measured as described in the materials and methods and
calculation of ATP-linked OCR was similar as described in
Figure 1C. (*P<0.05 as compared to cont group, #P<0.05
compared to siAKIP1 group, n=4). Values are presented as
mean ± SEM.
(TIF)
Table S1.  Primers used for cloning.
(PDF)
Table S2.  Primers used for Real-Time PCR.
(PDF)
Author Contributions
Conceived and designed the experiments: HHWS. Performed
the experiments: HY WT. Analyzed the data: HY WT.
Contributed reagents/materials/analysis tools: DPYK. Wrote
the manuscript: HHWS. Revised the manuscript: HHP RAdB
WHvG BDW HHWS.
References
1. Kitching R, Li H, Wong MJ, Kanaganayakam S, Kahn H et al. (2003)
Characterization of a novel human breast cancer associated gene
(BCA3) encoding an alternatively spliced proline-rich protein. Biochim
Biophys Acta 1625: 116-121. doi:10.1016/S0167-4781(02)00562-6.
PubMed: 12527432.
2. León DA, Cànaves JM (2003) In silico study of breast cancer
associated gene 3 using LION target engine and other tools.
BioTechniques 35: 1222-1226, 1228, 1230-1231 PubMed: 14682057.
3. Sastri M, Barraclough DM, Carmichael PT, Taylor SS (2005) A-kinase-
interacting protein localizes protein kinase A in the nucleus. Proc Natl
Acad Sci U S A 102: 349-354. doi:10.1073/pnas.0408608102. PubMed:
15630084.
4. Gao N, Asamitsu K, Hibi Y, Ueno T, Okamoto T (2008) AKIP1
enhances NF-kappaB-dependent gene expression by promoting the
nuclear retention and phosphorylation of p65. J Biol Chem 283:
7834-7843. doi:10.1074/jbc.M710285200. PubMed: 18178962.
5. Zimmerman R, Peng DJ, Lanz H, Zhang YH, Danen-Van Oorschot A et
al. (2012) PP2A inactivation is a crucial step in triggering apoptin-
induced tumor-selective cell killing. Cell Death Dis 3: e291.
6. Yu KP, Itokawa T, Zhu ML, Syam S, Seth A et al. (2007) Breast cancer-
associated gene 3 (BCA3) is a novel Rac1-interacting protein. J Bone
Miner Res 22: 628-637. doi:10.1359/jbmr.070105. PubMed: 17227220.
7. Leung TH, Ngan HY (2010) Interaction of TAp73 and breast cancer-
associated gene 3 enhances the sensitivity of cervical cancer cells in
response to irradiation-induced apoptosis. Cancer Res 70: 6486-6496.
doi:10.1158/0008-5472.CAN-10-0688. PubMed: 20647320.
8. Sastri M, Haushalter KJ, Panneerselvam M, Chang P, Fridolfsson H et
al. (2013) A kinase interacting protein (AKIP1) is a key regulator of
cardiac stress. Proc Natl Acad Sci U S A 110: e387-e396. doi:10.1073/
pnas.1220256110. PubMed: 23319652.
9. King CC, Sastri M, Chang P, Pennypacker J, Taylor SS (2011) The rate
of NF-kappaB nuclear translocation is regulated by PKA and A kinase
interacting protein 1. PLOS ONE 6: e18713. doi:10.1371/journal.pone.
0018713. PubMed: 21556136.
10. Gao N, Hibi Y, Cueno M, Asamitsu K, Okamoto T (2010) A-kinase-
interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in
NF-kappaB signaling. J Biol Chem 285: 28097-28104. doi:10.1074/
jbc.M110.116566. PubMed: 20562110.
11. Lu B, Yu H, Zwartbol M, Ruifrok WP, van Gilst WH et al. (2012)
Identification of hypertrophy and heart failure associated genes by
combining in vitro and in vivo models. Physiol Genomics 44: 443-454.
doi:10.1152/physiolgenomics.00148.2011. PubMed: 22353257.
12. Giusti B, Marini M, Rossi L, Lapini I, Magi A et al. (2009) Gene
expression profile of rat left ventricles reveals persisting changes
following chronic mild exercise protocol: Implications for
cardioprotection. BMC Genomics 10: 342. doi:
10.1186/1471-2164-10-342. PubMed: 19643001.
13. Abel ED, Doenst T (2011) Mitochondrial adaptations to physiological
vs. pathological cardiac hypertrophy. Cardiovasc Res 90: 234-242. doi:
10.1093/cvr/cvr015. PubMed: 21257612.
14. Lu B, Mahmud H, Maass AH, Yu B, van Gilst WH et al. (2010) The Plk1
inhibitor BI 2536 temporarily arrests primary cardiac fibroblasts in
mitosis and generates aneuploidy in vitro. PLOS ONE 5: e12963. doi:
10.1371/journal.pone.0012963. PubMed: 20886032.
15. Westenbrink BD, Ruifrok WP, Voors AA, Tilton RG, van Veldhuisen DJ
et al. (2010) Vascular endothelial growth factor is crucial for
erythropoietin-induced improvement of cardiac function in heart failure.
Cardiovasc Res 87: 30-39. doi:10.1093/cvr/cvq041. PubMed:
20139114.
16. Lu B, Tigchelaar W, Ruifrok WP, van Gilst WH, de Boer RA et al.
(2012) DHRS7c, a novel cardiomyocyte-expressed gene that is down-
regulated by adrenergic stimulation and in heart failure. Eur J Heart Fail
14: 5-13. doi:10.1093/eurjhf/hfr152. PubMed: 22143674.
17. Sansbury BE, Riggs DW, Brainard RE, Salabei JK, Jones SP et al.
(2011) Responses of hypertrophied myocytes to reactive species:
Implications for glycolysis and electrophile metabolism. Biochem J 435:
519-528. doi:10.1042/BJ20101390. PubMed: 21275902.
18. Gao F, Cheng J, Shi T, Yeh ET (2006) Neddylation of a breast cancer-
associated protein recruits a class III histone deacetylase that
represses NFkappaB-dependent transcription. Nat Cell Biol 8:
1171-1177. doi:10.1038/ncb1483. PubMed: 16998474.
19. Nemoto S, Fergusson MM, Finkel T (2005) SIRT1 functionally interacts
with the metabolic regulator and transcriptional coactivator
PGC-1{alpha}. J Biol Chem 280: 16456-16460. doi:10.1074/
jbc.M501485200. PubMed: 15716268.
20. Marchi S, Giorgi C, Suski JM, Agnoletto C, Bononi A et al. (2012)
Mitochondria-ros crosstalk in the control of cell death and aging. J
Signal Transduct 2012: 329635. PubMed: 22175013
21. Jastroch M, Divakaruni AS, Mookerjee S, Treberg JR, Brand MD
(2010) Mitochondrial proton and electron leaks. Essays Biochem 47:
53-67. doi:10.1042/bse0470053. PubMed: 20533900.
22. Muller F (2000) The nature and mechanism of superoxide production
by the electron transport chain: Its relevance to aging. J Am Aging
Assoc 23: 227-253. PubMed: 23604868.
23. Aubert G, Vega RB, Kelly DP (2013) Perturbations in the gene
regulatory pathways controlling mitochondrial energy production in the
failing heart. Biochim Biophys Acta 1833: 840-847. doi:10.1016/
j.bbamcr.2012.08.015. PubMed: 22964268.
24. Bugger H, Schwarzer M, Chen D, Schrepper A, Amorim PA et al.
(2010) Proteomic remodelling of mitochondrial oxidative pathways in
pressure overload-induced heart failure. Cardiovasc Res 85: 376-384.
doi:10.1093/cvr/cvp344. PubMed: 19843514.
25. Jüllig M, Hickey AJ, Chai CC, Skea GL, Middleditch MJ et al. (2008) Is
the failing heart out of fuel or a worn engine running rich? A study of
mitochondria in old spontaneously hypertensive rats. Proteomics 8:
2556-2572. doi:10.1002/pmic.200700977. PubMed: 18563753.
26. DeMarco VG, Habibi J, Whaley-Connell AT, Schneider RI, Heller RL et
al. (2008) Oxidative stress contributes to pulmonary hypertension in the
transgenic (mRen2)27 rat. Am J Physiol Heart Circ Physiol 294:
H2659-H2668. doi:10.1152/ajpheart.00953.2007. PubMed: 18424632.
27. Takimoto E, Champion HC, Li M, Ren S, Rodriguez ER et al. (2005)
Oxidant stress from nitric oxide synthase-3 uncoupling stimulates
cardiac pathologic remodeling from chronic pressure load. J Clin Invest
115: 1221-1231. doi:10.1172/JCI21968. PubMed: 15841206.
28. Kleikers PW, Wingler K, Hermans JJ, Diebold I, Altenhöfer S et al.
(2012) NADPH oxidases as a source of oxidative stress and molecular
target in ischemia/reperfusion injury. J Mol Med (Berl) 90: 1391-1406.
doi:10.1007/s00109-012-0963-3. PubMed: 23090009.
29. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN et al.
(2007) IL-33 and ST2 comprise a critical biomechanically induced and
cardioprotective signaling system. J Clin Invest 117: 1538-1549. doi:
10.1172/JCI30634. PubMed: 17492053.
30. Sharma S, Dewald O, Adrogue J, Salazar RL, Razeghi P et al. (2006)
Induction of antioxidant gene expression in a mouse model of ischemic
cardiomyopathy is dependent on reactive oxygen species. Free Radic
Biol Med 40: 2223-2231. doi:10.1016/j.freeradbiomed.2006.02.019.
PubMed: 16785036.
AKIP1 Enhances Mitochondrial Respiration
PLOS ONE | www.plosone.org 10 November 2013 | Volume 8 | Issue 11 | e80815
31. Horikawa YT, Panneerselvam M, Kawaraguchi Y, Tsutsumi YM, Ali SS
et al. (2011) Cardiac-specific overexpression of caveolin-3 attenuates
cardiac hypertrophy and increases natriuretic peptide expression and
signaling. J Am Coll Cardiol 57: 2273-2283. doi:10.1016/j.jacc.
2010.12.032. PubMed: 21616289.
32. Feiner EC, Chung P, Jasmin JF, Zhang J, Whitaker-Menezes D et al.
(2011) Left ventricular dysfunction in murine models of heart failure and
in failing human heart is associated with a selective decrease in the
expression of caveolin-3. J Card Fail 17: 253-263. doi:10.1016/
j.cardfail.2010.10.008. PubMed: 21362533.
33. Zamani P, Greenberg BH (2013) Novel vasodilators in heart failure.
Curr Heart Fail Rep 10: 1-11. doi:10.1007/s11897-012-0126-4.
PubMed: 23299783.
34. Hafstad AD, Nabeebaccus AA, Shah AM (2013) Novel aspects of ROS
signalling in heart failure. Basic Res Cardiol 108: 359-013-0359-8.
PubMed: 23740217.
AKIP1 Enhances Mitochondrial Respiration
PLOS ONE | www.plosone.org 11 November 2013 | Volume 8 | Issue 11 | e80815
